The global Synthetic Lethality-based Drugs and Targets market was valued at US$ million in 2023 and is projected to reach US$ million by 2030, at a CAGR of % during the forecast period.
The USA market for Global Synthetic Lethality-based Drugs and Targets market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The China market for Global Synthetic Lethality-based Drugs and Targets market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
The Europe market for Global Synthetic Lethality-based Drugs and Targets market is estimated to increase from USD million in 2023 to reach USD million by 2030, at a CAGR during the forecast period of 2023 through 2030.
This research report provides a comprehensive analysis of the Synthetic Lethality-based Drugs and Targets market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Synthetic Lethality-based Drugs and Targets market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Synthetic Lethality-based Drugs and Targets, challenges faced by the industry, and potential opportunities for market players.
The global Synthetic Lethality-based Drugs and Targets market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Synthetic Lethality-based Drugs and Targets market presents opportunities for various stakeholders, including Medical Research Institution, Hospital and Clinic. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Synthetic Lethality-based Drugs and Targets market. Additionally, the growing consumer demand present avenues for market expansion.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Synthetic Lethality-based Drugs and Targets market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Synthetic Lethality-based Drugs and Targets market.
Market Overview: The report provides a comprehensive overview of the Synthetic Lethality-based Drugs and Targets market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Monotherapy, Combination Therapy), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Synthetic Lethality-based Drugs and Targets market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Synthetic Lethality-based Drugs and Targets market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Synthetic Lethality-based Drugs and Targets market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Synthetic Lethality-based Drugs and Targets market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Synthetic Lethality-based Drugs and Targets market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Synthetic Lethality-based Drugs and Targets market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Synthetic Lethality-based Drugs and Targets, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Synthetic Lethality-based Drugs and Targets market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Synthetic Lethality-based Drugs and Targets market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
- Monotherapy
- Combination Therapy
Market segment by Application
- Medical Research Institution
- Hospital and Clinic
- Other
Global Synthetic Lethality-based Drugs and Targets Market Segment Percentages, By Region and Country, 2023 (%)
- North America (United States, Canada, Mexico)
- Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
- Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
- The Middle East and Africa (Middle East, Africa)
- South and Central America (Brazil, Argentina, Rest of SCA)
Major players covered
- AbbVie
- AstraZeneca
- BeiGene
- Clovis Oncology
- GlaxoSmithKline
- Pfizer
- AtlasMedx
- Chordia Therapeutics
- IDEAYA Biosciences
- Mission Therapeutics
- Repare Therapeutics
- Sierra Oncology
- SyntheX Labs
Outline of Major Chapters:
Chapter 1: Introduces the definition of Synthetic Lethality-based Drugs and Targets, market overview.
Chapter 2: Global Synthetic Lethality-based Drugs and Targets market size in revenue.
Chapter 3: Detailed analysis of Synthetic Lethality-based Drugs and Targets company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments
by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments
by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Synthetic Lethality-based Drugs and Targets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Synthetic Lethality-based Drugs and Targets Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Synthetic Lethality-based Drugs and Targets Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Synthetic Lethality-based Drugs and Targets Overall Market Size
2.1 Global Synthetic Lethality-based Drugs and Targets Market Size: 2023 VS 2030
2.2 Global Synthetic Lethality-based Drugs and Targets Market Size, Prospects & Forecasts: 2019-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Synthetic Lethality-based Drugs and Targets Players in Global Market
3.2 Top Global Synthetic Lethality-based Drugs and Targets Companies Ranked by Revenue
3.3 Global Synthetic Lethality-based Drugs and Targets Revenue by Companies
3.4 Top 3 and Top 5 Synthetic Lethality-based Drugs and Targets Companies in Global Market, by Revenue in 2023
3.5 Global Companies Synthetic Lethality-based Drugs and Targets Product Type
3.6 Tier 1, Tier 2 and Tier 3 Synthetic Lethality-based Drugs and Targets Players in Global Market
3.6.1 List of Global Tier 1 Synthetic Lethality-based Drugs and Targets Companies
3.6.2 List of Global Tier 2 and Tier 3 Synthetic Lethality-based Drugs and Targets Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Synthetic Lethality-based Drugs and Targets Market Size Markets, 2023 & 2030
4.1.2 Monotherapy
4.1.3 Combination Therapy
4.2 By Type - Global Synthetic Lethality-based Drugs and Targets Revenue & Forecasts
4.2.1 By Type - Global Synthetic Lethality-based Drugs and Targets Revenue, 2019-2024
4.2.2 By Type - Global Synthetic Lethality-based Drugs and Targets Revenue, 2025-2030
4.2.3 By Type - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Synthetic Lethality-based Drugs and Targets Market Size, 2023 & 2030
5.1.2 Medical Research Institution
5.1.3 Hospital and Clinic
5.1.4 Other
5.2 By Application - Global Synthetic Lethality-based Drugs and Targets Revenue & Forecasts
5.2.1 By Application - Global Synthetic Lethality-based Drugs and Targets Revenue, 2019-2024
5.2.2 By Application - Global Synthetic Lethality-based Drugs and Targets Revenue, 2025-2030
5.2.3 By Application - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030
6 Sights by Region
6.1 By Region - Global Synthetic Lethality-based Drugs and Targets Market Size, 2023 & 2030
6.2 By Region - Global Synthetic Lethality-based Drugs and Targets Revenue & Forecasts
6.2.1 By Region - Global Synthetic Lethality-based Drugs and Targets Revenue, 2019-2024
6.2.2 By Region - Global Synthetic Lethality-based Drugs and Targets Revenue, 2025-2030
6.2.3 By Region - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030
6.3 North America
6.3.1 By Country - North America Synthetic Lethality-based Drugs and Targets Revenue, 2019-2030
6.3.2 US Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.3.3 Canada Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.3.4 Mexico Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.4 Europe
6.4.1 By Country - Europe Synthetic Lethality-based Drugs and Targets Revenue, 2019-2030
6.4.2 Germany Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.4.3 France Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.4.4 U.K. Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.4.5 Italy Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.4.6 Russia Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.4.7 Nordic Countries Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.4.8 Benelux Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.5 Asia
6.5.1 By Region - Asia Synthetic Lethality-based Drugs and Targets Revenue, 2019-2030
6.5.2 China Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.5.3 Japan Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.5.4 South Korea Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.5.5 Southeast Asia Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.5.6 India Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.6 South America
6.6.1 By Country - South America Synthetic Lethality-based Drugs and Targets Revenue, 2019-2030
6.6.2 Brazil Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.6.3 Argentina Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue, 2019-2030
6.7.2 Turkey Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.7.3 Israel Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.7.4 Saudi Arabia Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
6.7.5 UAE Synthetic Lethality-based Drugs and Targets Market Size, 2019-2030
7 Synthetic Lethality-based Drugs and Targets Companies Profiles
7.1 AbbVie
7.1.1 AbbVie Company Summary
7.1.2 AbbVie Business Overview
7.1.3 AbbVie Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.1.4 AbbVie Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024)
7.1.5 AbbVie Key News & Latest Developments
7.2 AstraZeneca
7.2.1 AstraZeneca Company Summary
7.2.2 AstraZeneca Business Overview
7.2.3 AstraZeneca Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.2.4 AstraZeneca Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024)
7.2.5 AstraZeneca Key News & Latest Developments
7.3 BeiGene
7.3.1 BeiGene Company Summary
7.3.2 BeiGene Business Overview
7.3.3 BeiGene Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.3.4 BeiGene Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024)
7.3.5 BeiGene Key News & Latest Developments
7.4 Clovis Oncology
7.4.1 Clovis Oncology Company Summary
7.4.2 Clovis Oncology Business Overview
7.4.3 Clovis Oncology Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.4.4 Clovis Oncology Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024)
7.4.5 Clovis Oncology Key News & Latest Developments
7.5 GlaxoSmithKline
7.5.1 GlaxoSmithKline Company Summary
7.5.2 GlaxoSmithKline Business Overview
7.5.3 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.5.4 GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024)
7.5.5 GlaxoSmithKline Key News & Latest Developments
7.6 Pfizer
7.6.1 Pfizer Company Summary
7.6.2 Pfizer Business Overview
7.6.3 Pfizer Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.6.4 Pfizer Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024)
7.6.5 Pfizer Key News & Latest Developments
7.7 AtlasMedx
7.7.1 AtlasMedx Company Summary
7.7.2 AtlasMedx Business Overview
7.7.3 AtlasMedx Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.7.4 AtlasMedx Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024)
7.7.5 AtlasMedx Key News & Latest Developments
7.8 Chordia Therapeutics
7.8.1 Chordia Therapeutics Company Summary
7.8.2 Chordia Therapeutics Business Overview
7.8.3 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.8.4 Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024)
7.8.5 Chordia Therapeutics Key News & Latest Developments
7.9 IDEAYA Biosciences
7.9.1 IDEAYA Biosciences Company Summary
7.9.2 IDEAYA Biosciences Business Overview
7.9.3 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.9.4 IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024)
7.9.5 IDEAYA Biosciences Key News & Latest Developments
7.10 Mission Therapeutics
7.10.1 Mission Therapeutics Company Summary
7.10.2 Mission Therapeutics Business Overview
7.10.3 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.10.4 Mission Therapeutics Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024)
7.10.5 Mission Therapeutics Key News & Latest Developments
7.11 Repare Therapeutics
7.11.1 Repare Therapeutics Company Summary
7.11.2 Repare Therapeutics Business Overview
7.11.3 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.11.4 Repare Therapeutics Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024)
7.11.5 Repare Therapeutics Key News & Latest Developments
7.12 Sierra Oncology
7.12.1 Sierra Oncology Company Summary
7.12.2 Sierra Oncology Business Overview
7.12.3 Sierra Oncology Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.12.4 Sierra Oncology Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024)
7.12.5 Sierra Oncology Key News & Latest Developments
7.13 SyntheX Labs
7.13.1 SyntheX Labs Company Summary
7.13.2 SyntheX Labs Business Overview
7.13.3 SyntheX Labs Synthetic Lethality-based Drugs and Targets Major Product Offerings
7.13.4 SyntheX Labs Synthetic Lethality-based Drugs and Targets Revenue in Global Market (2019-2024)
7.13.5 SyntheX Labs Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Synthetic Lethality-based Drugs and Targets Market Opportunities & Trends in Global Market
Table 2. Synthetic Lethality-based Drugs and Targets Market Drivers in Global Market
Table 3. Synthetic Lethality-based Drugs and Targets Market Restraints in Global Market
Table 4. Key Players of Synthetic Lethality-based Drugs and Targets in Global Market
Table 5. Top Synthetic Lethality-based Drugs and Targets Players in Global Market, Ranking by Revenue (2023)
Table 6. Global Synthetic Lethality-based Drugs and Targets Revenue by Companies, (US$, Mn), 2019-2024
Table 7. Global Synthetic Lethality-based Drugs and Targets Revenue Share by Companies, 2019-2024
Table 8. Global Companies Synthetic Lethality-based Drugs and Targets Product Type
Table 9. List of Global Tier 1 Synthetic Lethality-based Drugs and Targets Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Synthetic Lethality-based Drugs and Targets Companies, Revenue (US$, Mn) in 2023 and Market Share
Table 11. By Type ? Global Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2023 & 2030
Table 12. By Type - Synthetic Lethality-based Drugs and Targets Revenue in Global (US$, Mn), 2019-2024
Table 13. By Type - Synthetic Lethality-based Drugs and Targets Revenue in Global (US$, Mn), 2025-2030
Table 14. By Application ? Global Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2023 & 2030
Table 15. By Application - Synthetic Lethality-based Drugs and Targets Revenue in Global (US$, Mn), 2019-2024
Table 16. By Application - Synthetic Lethality-based Drugs and Targets Revenue in Global (US$, Mn), 2025-2030
Table 17. By Region ? Global Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2023 & 2030
Table 18. By Region - Global Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), 2019-2024
Table 19. By Region - Global Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn), 2025-2030
Table 20. By Country - North America Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2024
Table 21. By Country - North America Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2025-2030
Table 22. By Country - Europe Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2024
Table 23. By Country - Europe Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2025-2030
Table 24. By Region - Asia Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2024
Table 25. By Region - Asia Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2025-2030
Table 26. By Country - South America Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2024
Table 27. By Country - South America Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2025-2030
Table 28. By Country - Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2024
Table 29. By Country - Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2025-2030
Table 30. AbbVie Company Summary
Table 31. AbbVie Synthetic Lethality-based Drugs and Targets Product Offerings
Table 32. AbbVie Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn) & (2019-2024)
Table 33. AbbVie Key News & Latest Developments
Table 34. AstraZeneca Company Summary
Table 35. AstraZeneca Synthetic Lethality-based Drugs and Targets Product Offerings
Table 36. AstraZeneca Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn) & (2019-2024)
Table 37. AstraZeneca Key News & Latest Developments
Table 38. BeiGene Company Summary
Table 39. BeiGene Synthetic Lethality-based Drugs and Targets Product Offerings
Table 40. BeiGene Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn) & (2019-2024)
Table 41. BeiGene Key News & Latest Developments
Table 42. Clovis Oncology Company Summary
Table 43. Clovis Oncology Synthetic Lethality-based Drugs and Targets Product Offerings
Table 44. Clovis Oncology Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn) & (2019-2024)
Table 45. Clovis Oncology Key News & Latest Developments
Table 46. GlaxoSmithKline Company Summary
Table 47. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Product Offerings
Table 48. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn) & (2019-2024)
Table 49. GlaxoSmithKline Key News & Latest Developments
Table 50. Pfizer Company Summary
Table 51. Pfizer Synthetic Lethality-based Drugs and Targets Product Offerings
Table 52. Pfizer Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn) & (2019-2024)
Table 53. Pfizer Key News & Latest Developments
Table 54. AtlasMedx Company Summary
Table 55. AtlasMedx Synthetic Lethality-based Drugs and Targets Product Offerings
Table 56. AtlasMedx Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn) & (2019-2024)
Table 57. AtlasMedx Key News & Latest Developments
Table 58. Chordia Therapeutics Company Summary
Table 59. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Product Offerings
Table 60. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn) & (2019-2024)
Table 61. Chordia Therapeutics Key News & Latest Developments
Table 62. IDEAYA Biosciences Company Summary
Table 63. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Product Offerings
Table 64. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn) & (2019-2024)
Table 65. IDEAYA Biosciences Key News & Latest Developments
Table 66. Mission Therapeutics Company Summary
Table 67. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Product Offerings
Table 68. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn) & (2019-2024)
Table 69. Mission Therapeutics Key News & Latest Developments
Table 70. Repare Therapeutics Company Summary
Table 71. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Product Offerings
Table 72. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn) & (2019-2024)
Table 73. Repare Therapeutics Key News & Latest Developments
Table 74. Sierra Oncology Company Summary
Table 75. Sierra Oncology Synthetic Lethality-based Drugs and Targets Product Offerings
Table 76. Sierra Oncology Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn) & (2019-2024)
Table 77. Sierra Oncology Key News & Latest Developments
Table 78. SyntheX Labs Company Summary
Table 79. SyntheX Labs Synthetic Lethality-based Drugs and Targets Product Offerings
Table 80. SyntheX Labs Synthetic Lethality-based Drugs and Targets Revenue (US$, Mn) & (2019-2024)
Table 81. SyntheX Labs Key News & Latest Developments
List of Figures
Figure 1. Synthetic Lethality-based Drugs and Targets Segment by Type in 2023
Figure 2. Synthetic Lethality-based Drugs and Targets Segment by Application in 2023
Figure 3. Global Synthetic Lethality-based Drugs and Targets Market Overview: 2023
Figure 4. Key Caveats
Figure 5. Global Synthetic Lethality-based Drugs and Targets Market Size: 2023 VS 2030 (US$, Mn)
Figure 6. Global Synthetic Lethality-based Drugs and Targets Revenue, 2019-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Synthetic Lethality-based Drugs and Targets Revenue in 2023
Figure 8. By Type - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030
Figure 9. By Application - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030
Figure 10. By Type - Global Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2023 & 2030
Figure 11. By Type - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030
Figure 12. By Application - Global Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2023 & 2030
Figure 13. By Application - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030
Figure 14. By Region - Global Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030
Figure 15. By Country - North America Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030
Figure 16. US Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 17. Canada Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 18. Mexico Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 19. By Country - Europe Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030
Figure 20. Germany Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 21. France Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 22. U.K. Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 23. Italy Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 24. Russia Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 25. Nordic Countries Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 26. Benelux Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 27. By Region - Asia Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030
Figure 28. China Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 29. Japan Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 30. South Korea Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 31. Southeast Asia Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 32. India Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 33. By Country - South America Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030
Figure 34. Brazil Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 35. Argentina Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 36. By Country - Middle East & Africa Synthetic Lethality-based Drugs and Targets Revenue Market Share, 2019-2030
Figure 37. Turkey Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 38. Israel Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 39. Saudi Arabia Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 40. UAE Synthetic Lethality-based Drugs and Targets Revenue, (US$, Mn), 2019-2030
Figure 41. AbbVie Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 42. AstraZeneca Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 43. BeiGene Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 44. Clovis Oncology Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 45. GlaxoSmithKline Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 46. Pfizer Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 47. AtlasMedx Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 48. Chordia Therapeutics Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 49. IDEAYA Biosciences Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 50. Mission Therapeutics Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 51. Repare Therapeutics Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 52. Sierra Oncology Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
Figure 53. SyntheX Labs Synthetic Lethality-based Drugs and Targets Revenue Year Over Year Growth (US$, Mn) & (2019-2024)
